Robert Half
RHI
$29.44
+3.66%
Robert Half Inc. is a specialized staffing and employment services firm operating in the fragmented U.S. market, providing temporary, permanent, and outcome-based staffing solutions primarily in finance, accounting, technology, legal, marketing, and administrative fields, supplemented by its Protiviti consulting arm focused on technology, risk, and compliance. The company is a well-established, specialized player known for its deep industry expertise and long-standing client relationships. The current investor narrative is heavily influenced by the stock's significant underperformance relative to the broader market, as indicated by a -64.79% one-year relative strength figure, suggesting intense debate around its cyclical sensitivity to economic conditions, potential for a recovery in hiring demand, and its ability to maintain its dividend amidst a challenging revenue environment.…
RHI
Robert Half
$29.44
Related headlines
Investment Opinion: Should I buy RHI Today?
Rating: Hold. The core thesis is that RHI presents a high-risk, high-potential-reward value proposition where the anticipated earnings recovery is already partially priced in, but significant fundamental risks remain that could derail it.
The Hold rating is supported by a forward P/E of 14.28x, which prices in a recovery but not perfection, a strong balance sheet (D/E of 0.33) providing downside cushion, and a substantial 8.76% dividend yield that offers compensation for waiting. However, this is counterbalanced by severely compressed margins (operating margin 1.42%), an unsustainable payout ratio of 179%, and the stock's history of severe underperformance (-36.58% over one year).
The thesis would upgrade to a Buy if the company demonstrates sequential margin improvement and provides guidance confirming the path to the $2.99 EPS target, or if the price falls meaningfully below the 52-week low, offering a greater margin of safety. It would downgrade to a Sell if forward EPS estimates are cut, the dividend is reduced, or the stock fails to hold the $21.83 support level. Relative to its own distressed valuation and the cyclical risks, the stock is fairly valued, trading at a discount to its trailing earnings but a premium to its current depressed profitability.
Sign up to view all
RHI 12-Month Price Forecast
The outlook for RHI is a coin flip between a cyclical recovery and a prolonged slump. The neutral stance reflects the offsetting forces of deep value and high fundamental risk. The forward valuation is not demanding if earnings recover, but the path is fraught with uncertainty given compressed margins. The high dividend yield acts as an attractive call option on stability. Confidence is medium due to limited analyst coverage and the binary nature of the earnings recovery catalyst. The stance would upgrade to bullish on confirmation of margin expansion in upcoming quarters or a sustained breakout above $34.61. It would turn bearish on a dividend cut or a break below the 52-week low.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Robert Half's 12-month outlook, with a consensus price target around $38.27 and implied upside of +30.0% versus the current price.
Average Target
$38.27
3 analysts
Implied Upside
+30.0%
vs. current price
Analyst Count
3
covering this stock
Price Range
$24 - $38
Analyst target range
Analyst coverage for RHI is limited, with only 3 analysts providing estimates, which is indicative of a mid-cap stock with potentially lower institutional interest and can lead to less efficient price discovery and higher volatility. The consensus provides an estimated EPS average of $2.99 for the forward period, with a narrow range between a low of $2.96 and a high of $3.02, and an estimated revenue average of $6.07 billion; the tight EPS range suggests a high degree of conviction in near-term earnings projections among the few covering analysts, though the minimal coverage overall means the sentiment signal is weak and investors should place greater emphasis on fundamental and macroeconomic indicators for this cyclical name.
Bulls vs Bears: RHI Investment Factors
The evidence for RHI presents a classic battle between deep value and cyclical risk. The bull case is anchored in a compelling valuation (forward P/E of 14.28x, P/S of 0.51x), a strong balance sheet, and a high dividend yield, suggesting the market has over-penalized the stock for cyclical woes. The bear case highlights severe profitability compression, an unsustainable dividend payout, and persistent technical weakness, arguing the challenges are fundamental and not just sentiment-driven. Currently, the bear side has stronger evidence due to the stock's dramatic underperformance and precarious earnings coverage of the dividend. The single most important tension in the investment debate is the timing and magnitude of an earnings recovery. If forward EPS of ~$2.99 is achieved, the stock is profoundly undervalued; if the cyclical downturn persists longer than expected, the dividend is at risk and the value trap narrative will prevail.
Bullish
- Deep Value Valuation: The stock trades at a forward P/E of 14.28x, a significant discount to its trailing P/E of 20.45x, implying the market expects a substantial earnings recovery. With a Price-to-Sales ratio of 0.51x and a price near 40% of its 52-week range, the valuation appears to be pricing in significant cyclical pessimism, offering a margin of safety.
- Strong Recent Momentum & Short Squeeze Potential: The stock has gained 20.56% over the past three months, sharply diverging from its one-year downtrend of -36.58%. This rally is occurring alongside a high short ratio of 9.01, indicating a potential short squeeze could amplify any positive fundamental news or market rotation into value.
- Conservative Balance Sheet: The company maintains a low debt-to-equity ratio of 0.33 and a healthy current ratio of 1.52, indicating strong liquidity and low financial risk. This robust balance sheet provides resilience during economic downturns and flexibility to maintain its dividend or invest opportunistically.
- Attractive Dividend Yield: RHI offers a dividend yield of 8.76%, which is substantial for income-focused investors. While the payout ratio of 179% is a concern, the company's strong balance sheet and cash flow (P/CF of 8.50x) suggest it has the financial capacity to sustain the dividend through a temporary earnings trough.
Bearish
- Extreme Cyclical Sensitivity & Underperformance: RHI has significantly underperformed the market, with a -64.79% one-year relative strength figure and a -36.58% one-year price change, highlighting its high sensitivity to economic cycles and weak hiring demand. The stock's beta of 0.79 indicates it has been less volatile than the market, yet its deep decline suggests company-specific or sector-specific headwinds are severe.
- Unsustainable Dividend Payout: The dividend payout ratio stands at 179%, meaning dividends are not covered by current earnings, posing a clear sustainability risk. If profitability, reflected in a net margin of 2.47% and operating margin of 1.42%, does not recover as forecasted, a dividend cut could trigger further selling pressure.
- Severely Compressed Profitability: Key profitability metrics are under intense pressure, with an operating margin of just 1.42% and a return on assets of 1.72%. This indicates high operating leverage, where even minor revenue declines significantly impact the bottom line, making near-term earnings highly volatile and unpredictable.
- Limited Analyst Coverage & Sentiment: Only 3 analysts provide coverage for RHI, indicating lower institutional interest and potentially less efficient price discovery. This limited coverage weakens the sentiment signal and means the stock is more susceptible to being overlooked or mispriced based on macro narratives rather than fundamentals.
RHI Technical Analysis
The stock is in a pronounced long-term downtrend, evidenced by a -36.58% one-year price change, and is trading near the lower end of its 52-week range, with the current price of $29.44 representing approximately 40% of the range between the 52-week low of $21.83 and high of $46.21, indicating a deep value territory that may attract contrarian investors but also reflects persistent fundamental headwinds. Recent momentum shows a significant divergence, with a strong +20.56% three-month gain and a +8.28% one-month gain, sharply contrasting the one-year downtrend and suggesting a potential bottoming process or short-term recovery rally, though this is occurring against a backdrop of high short interest with a short ratio of 9.01, which could be fueling a squeeze. Key technical levels are clearly defined by the 52-week low of $21.83 as critical support and the 52-week high of $46.21 as major resistance; a sustained breakout above the recent high of $34.61 (from January 30th) would be needed to signal a more durable trend reversal, while the stock's beta of 0.79 indicates it has been 21% less volatile than the market during this turbulent period, which may appeal to risk-averse investors seeking exposure to a potential economic rebound.
Beta
0.79
0.79x market volatility
Max Drawdown
-54.6%
Largest decline past year
52-Week Range
$22-$46
Price range past year
Annual Return
-36.6%
Cumulative gain past year
| Period | RHI Return | S&P 500 |
|---|---|---|
| 1m | +8.3% | +5.0% |
| 3m | +20.6% | +10.2% |
| 6m | +8.9% | +11.0% |
| 1y | -36.6% | +28.4% |
| ytd | +7.7% | +10.9% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
RHI Fundamental Analysis
Revenue trajectory analysis is constrained as specific quarterly revenue and growth rate figures are not available in the provided data; however, the estimated full-year revenue consensus of $6.07 billion provides a forward-looking anchor, and the stock's significant price decline suggests the market is pricing in a decelerating or challenging top-line environment typical of the cyclical staffing industry. Profitability metrics show a company that is profitable but with compressed margins, citing a net margin of 2.47%, a gross margin of 37.23%, and a trailing EPS of $0.049; the operating margin of 1.42% indicates high operating leverage and sensitivity to revenue fluctuations, while a payout ratio of 179% signals dividends are currently not fully covered by earnings, posing a sustainability question if profitability does not recover. The balance sheet appears conservatively leveraged with a debt-to-equity ratio of 0.33 and a healthy current ratio of 1.52, indicating good liquidity and low financial risk; however, the return on equity of 10.42% and return on assets of 1.72% reflect modest capital efficiency in the current environment, and the price-to-cash-flow ratio of 8.50 suggests the market is not assigning a premium for its cash generation capabilities.
Quarterly Revenue
N/A
N/A
Revenue YoY Growth
N/A
YoY Comparison
Gross Margin
N/A
Latest Quarter
Free Cash Flow
N/A
Last 12 Months
Open an Account, get $2 TSLA now!
Valuation Analysis: Is RHI Overvalued?
The primary valuation metric selected is the Price-to-Earnings (PE) ratio because the company is profitable, with a positive net income and EPS. The trailing PE is 20.45x, while the forward PE is notably lower at 14.28x; this significant gap implies the market expects a substantial recovery in earnings over the next twelve months, aligning with the positive recent price momentum. Compared to industry averages, direct peer multiples are not provided, but the stock's valuation appears grounded with a Price-to-Sales ratio of 0.51x and an EV/EBITDA of 10.95x; the forward PE of 14.28x, if below a hypothetical sector average, could indicate a discount priced for cyclical risk or inferior growth prospects. Historical context for the stock's own valuation range is unavailable due to missing historical ratios data; however, the current price near 52-week lows and the depressed one-year performance suggest the valuation is likely at the lower end of its historical band, which may represent a value opportunity if the company's fundamentals stabilize, but could also reflect justified pessimism about its cyclical outlook.
PE
20.4x
Latest Quarter
vs. Historical
N/A
5-Year PE Range 17x~59x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
11.0x
Enterprise Value Multiple
Investment Risk Disclosure
Financial & Operational Risks center on profitability and dividend sustainability. With an operating margin of 1.42% and a net margin of 2.47%, the company has minimal buffer against further revenue softness. The dividend payout ratio of 179% is a glaring red flag, indicating the current $0.049 EPS cannot support the dividend, forcing reliance on balance sheet cash. Revenue concentration in the cyclical U.S. staffing market means the company lacks geographic diversification to offset a domestic economic slowdown.
Market & Competitive Risks are dominated by valuation compression and sector sentiment. Although the forward P/E of 14.28x appears reasonable, it could compress further if the expected earnings recovery is delayed, especially given the stock's -64.79% relative underperformance suggests it is out of favor. Operating in the fragmented U.S. staffing industry, RHI faces intense competition that could pressure already thin margins. Its beta of 0.79 indicates lower market correlation, but this has not protected it from severe idiosyncratic decline.
The Worst-Case Scenario involves a prolonged economic downturn causing a deeper-than-expected slump in permanent placement fees, a key high-margin revenue stream. This would lead to a significant miss on the forward EPS target of $2.99, forcing a dividend cut. Such an event could trigger a wave of selling from income-focused investors and short sellers capitalizing on the breakdown. The realistic downside could see the stock re-test its 52-week low of $21.83, representing a -26% decline from the current price of $29.44, with potential for further losses if the dividend is eliminated.
FAQ
The key risks are, in order of severity: 1) Dividend Sustainability Risk: The 179% payout ratio means the dividend is not covered by earnings, risking a cut. 2) Cyclical Earnings Risk: With an operating margin of just 1.42%, earnings are highly sensitive to any revenue softness, jeopardizing the recovery thesis. 3) Sentiment & Coverage Risk: Limited analyst coverage (3 analysts) can lead to poor price discovery and heightened volatility. 4) Technical Risk: The stock remains in a long-term downtrend, 36% below its 52-week high, indicating persistent selling pressure.
The 12-month forecast presents three scenarios. The Base Case (50% probability) sees a gradual recovery, with a target range of $30-$35, assuming the company meets its forward EPS target of $2.99. The Bull Case (30% probability) targets $38-$46 on a strong economic rebound and multiple expansion. The Bear Case (20% probability) warns of a drop to $22-$26 if earnings disappoint and the dividend is cut. The Base Case is most likely, hinging on the assumption that corporate hiring stabilizes in the latter half of the year.
RHI's valuation sends mixed signals. Based on trailing depressed earnings (P/E of 20.45x), it looks expensive. However, the forward P/E of 14.28x, Price-to-Sales of 0.51x, and price near 52-week lows suggest the market is pricing in significant cyclical risk, creating potential undervaluation. The valuation is fair relative to the substantial recovery already embedded in forward estimates. The market is effectively paying a fair price for a promised earnings rebound that is far from guaranteed.
RHI is a speculative buy only for investors with a high risk tolerance and a long-term horizon. The potential reward is substantial, with a forward P/E of 14.28x implying significant upside if the company hits its $2.99 EPS target. However, the risks are equally high, including an unsustainable 179% dividend payout ratio and severe profitability compression. It could be a good buy for contrarian value investors seeking high yield and betting on an economic recovery, but it is a poor choice for those seeking stability or growth.
RHI is unsuitable for short-term trading due to its high volatility, low analyst coverage, and dependence on macroeconomic cycles. It is best considered a long-term (3+ year) investment for investors willing to endure volatility to capture a potential cyclical recovery and collect a high dividend yield while waiting. The stock's beta of 0.79 suggests it is less volatile than the market, but its 54.64% max drawdown shows it can experience severe declines, necessitating a patient, long-term holding period to realize the value thesis.